Precision Optical Guidance for Oral Biopsy Based on Next-Generation Hallmarks of Cancer
基于下一代癌症标志的口腔活检精密光学引导
基本信息
- 批准号:10326402
- 负责人:
- 金额:$ 63.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-25 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAlgorithmsAreaBackBenignBiopsyCancer PatientCellsCollagenDevelopmentDiagnosisDiseaseDysplasiaEarly DiagnosisEarly treatmentEnsureEpithelialExcisionFluorescenceFutureGenomic InstabilityGoalsGoldHigh grade dysplasiaImageImaging technologyIncidenceLesionLeukoplakiaLightMalignant - descriptorMalignant NeoplasmsMapsMicroscopeMild DysplasiaModalityMolecularMorbidity - disease rateMorphologyMouth NeoplasmsMovementMucous MembraneMultimodal ImagingMutationNeoplasm MetastasisNeoplasmsNuclearOpticsOralOral DiagnosisOral mucous membrane structureOutcomePathologicPatient-Focused OutcomesPatientsPositioning AttributeProcessPrognosisPropertyResearchResolutionRiskScreening for Oral CancerSeveritiesSignal TransductionSiteSpecificityStage at DiagnosisSurfaceSurvival RateSystemTechnologyTimeTissuesWorkangiogenesisbasecostdensitydigitalfluorescence imagingglobal healthhigh resolution imaginghigh riskimage guidedimaging modalityimaging probeimaging systemimprovedmalignant mouth neoplasmmortalitymouth squamous cell carcinomamultimodalityneoplasticnext generationnoveloptical imagingoral cavity epitheliumoral dysplasiaoral lesionoral tissuepreventsurvival prediction
项目摘要
Project Summary/Abstract:
With over 300,000 new cases per year and a mortality rate of approximately 50%, oral cancer is a major global health
issue. The stage at diagnosis is the most important predictor of survival, and unfortunately, most patients are diagnosed
at a late stage. Oral cancer is preceded by visible mucosal changes which are designated oral potentially malignant
disorders (OPMD). Invasive biopsy of oral lesions is the gold standard to diagnose oral dysplasia and cancer, and
pathologic diagnosis of dysplasia is the best indicator of risk for oral cancer development. Dysplasia often arises in
patients with OPMDs; however, most practitioners lack expertise to distinguish OPMDs from benign lesions. It is difficult
even for experts to determine which oral lesions are at highest risk to contain dysplasia and should be biopsied. The goal
of this proposal is to develop and validate an Active Biopsy Guidance (ABG) optical imaging system, consisting of an
optical mapping scope and a high resolution microscope, to help clinicians determine precisely when and where to
biopsy suspicious oral lesions. The ABG system will integrate several optical imaging modalities to non-invasively probe
key molecular and morphologic changes associated with the next-generation hallmarks of cancer.
In Aim 1, we will develop a compact optical mapping scope that uses Digital Light Processing technology to capture
white light and auto-fluorescence images and actively project onto the oral mucosa a map highlighting areas at high risk
for oral dysplasia and cancer based on loss of collagen fluorescence (a signal of invasion and metastasis) and alterations
in epithelial NAD(P)H and FAD fluorescence (a signal of de-regulated cellular energetics). The mapping scope will
function as the first step in the image guidance sequence, projecting a visible map of high-risk regions on the oral tissue.
We will develop tracking algorithms to adjust the projected map to ensure accurate positioning despite patient
movement. In Aim 2, we will develop a low-cost fluorescence and reflectance high resolution microscope capable of
imaging nuclear morphology in the oral epithelium (a signal of sustained proliferative signaling, genome instability and
mutation) and microvascular density and morphology (a signal of angiogenesis). The high resolution probe will serve as a
confirmation modality to improve specificity. In Aim 3, we will integrate the optical mapping scope and high resolution
microscope into a single, compact Active Biopsy Guidance system and validate its ability to provide real-time precise
guidance for selection of oral biopsy sites in a study of high-risk patients undergoing surveillance for oral cancer.
Combining widefield autofluorescence imaging and high resolution imaging of nuclear and microvessel morphology will
provide a biologically directed approach to help clinicians precisely determine where and when to biopsy suspicious oral
lesions, achieving both high sensitivity and high specificity.
The impact of this research will be to provide interactive imaging technology that will enable earlier detection of oral
neoplasia and better patient outcomes addressing a long-standing, significant global health challenge.
项目概要/摘要:
口腔癌每年新发病例超过30万例,死亡率约为50%,是全球主要的健康问题。
问题.诊断时的分期是最重要的生存预测因素,不幸的是,大多数患者在确诊时
在后期阶段。口腔癌发生之前会出现可见的粘膜变化,这些变化被认为是口腔潜在的恶性病变
疾病(OPMD)。口腔病变的侵入性活检是诊断口腔发育不良和癌症的金标准,
病理诊断的发育异常是最好的指标的风险,口腔癌的发展。发育不良通常发生在
OPMD患者;然而,大多数医生缺乏区分OPMD和良性病变的专业知识。很难
甚至对于专家来说,确定哪些口腔病变具有最高的包含发育不良的风险,并且应该进行活检。目标
该提案的一个目的是开发和验证主动活检引导(ABG)光学成像系统,该系统由以下部分组成:
光学映射范围和高分辨率显微镜,以帮助临床医生准确地确定何时何地
活检可疑的口腔病变。ABG系统将集成几种光学成像模式,
与下一代癌症标志相关的关键分子和形态学变化。
在目标1中,我们将开发一种紧凑的光学映射范围,该范围使用数字光处理技术来捕获
白色光和自体荧光图像,并主动将突出显示高危区域的地图投射到口腔粘膜上
基于胶原荧光的丧失(侵袭和转移的信号)和改变,
在上皮NAD(P)H和FAD荧光(细胞能量失调的信号)。映射范围将
作为图像引导序列中的第一步,在口腔组织上投影高风险区域的可见图。
我们将开发跟踪算法来调整投影图,以确保准确定位,
运动在目标2中,我们将开发低成本的荧光和反射高分辨率显微镜,
口腔上皮细胞核形态成像(持续增殖信号、基因组不稳定性和
突变)和微血管密度和形态(血管生成的信号)。高分辨率探测器将作为
确认模式,以提高特异性。在目标3中,我们将集成光学映射范围和高分辨率
将显微镜整合到一个紧凑的主动活检引导系统中,并验证其提供实时精确
在接受口腔癌监测的高危患者研究中选择口腔活检部位的指南。
将宽视野自体荧光成像与核和微血管形态的高分辨率成像相结合,
提供一种生物学指导的方法,帮助临床医生精确地确定何时何地对可疑的口腔进行活检。
病变,实现高灵敏度和高特异性。
这项研究的影响将是提供交互式成像技术,使口腔癌的早期检测成为可能。
肿瘤和更好的患者结局,解决长期存在的重大全球健康挑战。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann M Gillenwater其他文献
Ann M Gillenwater的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann M Gillenwater', 18)}}的其他基金
Deep learning microscope for slide-free and digital histology
用于无载玻片和数字组织学的深度学习显微镜
- 批准号:
10503039 - 财政年份:2022
- 资助金额:
$ 63.41万 - 项目类别:
Deep learning microscope for slide-free and digital histology
用于无载玻片和数字组织学的深度学习显微镜
- 批准号:
10664026 - 财政年份:2022
- 资助金额:
$ 63.41万 - 项目类别:
Mobile Imaging for Oral Cancer Screening Programs in Rural US Settings
美国农村地区口腔癌筛查项目的移动成像
- 批准号:
10396044 - 财政年份:2021
- 资助金额:
$ 63.41万 - 项目类别:
Mobile Imaging for Oral Cancer Screening Programs in Rural US Settings
美国农村地区口腔癌筛查项目的移动成像
- 批准号:
10193591 - 财政年份:2021
- 资助金额:
$ 63.41万 - 项目类别:
Precision Optical Guidance for Oral Biopsy Based on Next-Generation Hallmarks of Cancer
基于下一代癌症标志的口腔活检精密光学引导
- 批准号:
10565685 - 财政年份:2020
- 资助金额:
$ 63.41万 - 项目类别:
(PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field Cancerization
(PQC2) 口腔癌化中侵袭性克隆的光学标志
- 批准号:
9319642 - 财政年份:2014
- 资助金额:
$ 63.41万 - 项目类别:
(PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field Cancerization
(PQC2) 口腔癌化中侵袭性克隆的光学标志
- 批准号:
8912436 - 财政年份:2014
- 资助金额:
$ 63.41万 - 项目类别:
Oral Screening in India using Optical Imaging Technology
印度使用光学成像技术进行口腔筛查
- 批准号:
7290903 - 财政年份:2007
- 资助金额:
$ 63.41万 - 项目类别:
Oral Screening in India using Optical Imaging Technology
印度使用光学成像技术进行口腔筛查
- 批准号:
7463924 - 财政年份:2007
- 资助金额:
$ 63.41万 - 项目类别:
Oral Screening in India using Optical Imaging Technology
印度使用光学成像技术进行口腔筛查
- 批准号:
7615710 - 财政年份:2007
- 资助金额:
$ 63.41万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 63.41万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 63.41万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 63.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 63.41万 - 项目类别:
Studentship